Scarica l'app Stockscreener
39.35
0.51%
-0.20
Precedente Chiudi:
$39.55
Aprire:
$39.55
Volume 24 ore:
960.24K
Relative Volume:
1.56
Capitalizzazione di mercato:
$1.27B
Reddito:
$4.85M
Utile/perdita netta:
$-114.75M
Rapporto P/E:
-12.11
EPS:
-3.25
Flusso di cassa netto:
$-100.36M
1 W Prestazione:
+3.91%
1M Prestazione:
+66.95%
6M Prestazione:
+116.92%
1 anno Prestazione:
+43.72%
Intervallo 1D:
$38.73
$40.16
Intervallo di 1 settimana:
$35.50
$40.16
Portata 52W:
$13.37
$40.16
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
Nome
Dianthus Therapeutics Inc
Settore
Industria
Telefono
929-999-4055
Indirizzo
7 TIMES SQUARE, NEW YORK
Confronta DNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNTH
Dianthus Therapeutics Inc
|
39.35 | 1.57B | 4.85M | -114.75M | -100.36M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-02 | Iniziato | William Blair | Outperform |
| 2024-12-20 | Iniziato | TD Cowen | Buy |
| 2024-10-03 | Iniziato | Oppenheimer | Outperform |
| 2024-07-26 | Iniziato | Robert W. Baird | Outperform |
| 2024-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-02-15 | Iniziato | Stifel | Buy |
| 2023-12-26 | Iniziato | Jefferies | Buy |
| 2023-11-22 | Iniziato | Wedbush | Outperform |
| 2023-10-30 | Iniziato | Guggenheim | Buy |
| 2023-09-28 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Downgrade | Goldman | Buy → Neutral |
| 2022-01-06 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-08-20 | Ripresa | Goldman | Neutral |
| 2021-08-03 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-22 | Reiterato | B. Riley Securities | Buy |
| 2021-06-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-18 | Iniziato | B. Riley Securities | Buy |
| 2021-01-07 | Iniziato | Mizuho | Buy |
| 2020-06-08 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-03-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-03-15 | Iniziato | Raymond James | Outperform |
Mostra tutto
Dianthus Therapeutics Inc Borsa (DNTH) Ultime notizie
Dianthus Therapeutics (DNTH) Hits New High as Drug Trial Sparks Optimism for Blockbuster Potential - MSN
How Dianthus Therapeutics Inc. stock benefits from global expansionJobs Report & Weekly Breakout Opportunity Watchlist - newser.com
Dianthus Therapeutics stock hits 52-week high at 40.0 USD By Investing.com - Investing.com South Africa
Clear Street Initiates Buy on Dianthus Therapeutics, Inc. (DNTH) With $100 Price Target - MSN
Dianthus Therapeutics stock hits 52-week high at 40.0 USD - Investing.com
Dianthus Therapeutics (NASDAQ:DNTH) Hits New 1-Year HighHere's Why - MarketBeat
What drives Dianthus Therapeutics Inc stock priceTechnical Resistance Breaks & Access Free Tools and Start Investing - earlytimes.in
Will Dianthus Therapeutics Inc. continue its uptrendPortfolio Value Summary & Low Drawdown Investment Ideas - newser.com
Volume spikes in Dianthus Therapeutics Inc. stock – what they meanWeekly Gains Report & Safe Capital Growth Trade Ideas - newser.com
Why retail investors pile into Dianthus Therapeutics Inc. stockPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Can Dianthus Therapeutics Inc. stock resist sector downturnsJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com
Why Dianthus Therapeutics Inc. is moving todayEarnings Beat & AI Optimized Trade Strategies - newser.com
Is Dianthus Therapeutics Inc. (87E) stock a buy before new product rolloutEarnings Miss & Expert Verified Movement Alerts - newser.com
What indicators show strength in Dianthus Therapeutics Inc.Market Sentiment Summary & Technical Entry and Exit Tips - newser.com
What technical models suggest about Dianthus Therapeutics Inc.’s comebackLayoff News & AI Based Buy and Sell Signals - newser.com
Is Dianthus Therapeutics Inc. (87E) stock at risk of policy regulationQuarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
What Wall Street predicts for Dianthus Therapeutics Inc. stock priceNew Guidance & Smart Investment Allocation Insights - newser.com
Advanced analytics toolkit walkthrough for Dianthus Therapeutics Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Can machine learning forecast Dianthus Therapeutics Inc. recoveryWeekly Trade Summary & Weekly Stock Performance Updates - newser.com
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Dianthus Therapeutics Inc Azioni (DNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):